文献速递临床试验与 GCP基础与转化研究

无症状颈动脉狭窄伴血流动力学障碍的血运重建与认知结局:CREST-H子研究

Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01

CREST-H子研究纳入291例无症状颈动脉狭窄≥70%且基线认知减退的患者,评估血运重建联合强化内科治疗与单纯强化内科治疗对1年认知复合z评分的影响是否随基线血流动力学障碍程度而异。结果显示治疗组间认知无差异,交互作用不显著,提示血运重建未通过恢复脑血流改善慢性无症状颈动脉狭窄的认知障碍。

要点

  • 无症状颈动脉狭窄≥70%伴基线认知减退者,血运重建未显著改善1年认知。
  • 血运重建与单纯强化内科治疗的认知效应不随基线血流动力学障碍程度改变。
  • 慢性无症状颈动脉狭窄的认知障碍可能非单纯低灌注所致。

核心结论

  • 在基线认知减退的无症状颈动脉狭窄患者中,血运重建与单纯强化内科治疗相比,1年认知复合z评分无差异。
  • 治疗组与基线血流动力学障碍程度的交互作用不显著,提示血运重建未通过恢复脑血流改善认知。

研究设计与样本

  • CREST-2随机临床试验的多中心3期子研究,2018年1月至2024年7月纳入北美61个中心。
  • 筛查CREST-2中2485例,607例筛查,392例入组;最终291例有完整数据用于分析。
  • 纳入35-86岁、无痴呆、教育程度八年级以上、单侧无症状颈动脉狭窄≥70%的成人。
  • 干预为颈动脉血运重建(内膜剥脱术或支架)联合强化内科治疗 vs 单纯强化内科治疗。
  • 基线血流动力学障碍通过MR或CT灌注成像评估,以患侧与对侧半球对比剂达峰时间差定义。

主要发现

  • 291例完整数据中,51例基线认知减退(血运重建组25例,单纯强化内科治疗组26例)。
  • 血运重建组认知z评分基线-1.36(0.51),1年-1.17(0.47);单纯强化内科治疗组基线-1.34(0.83),1年-1.01(0.97)。
  • 调整治疗组×血流动力学状态交互作用及其他协变量后,1年认知z评分调整差异为-0.15 SD(95%CI -0.54至0.24)。

临床怎么用

  • 对于无症状颈动脉狭窄≥70%伴认知减退的患者,不应期望血运重建能改善认知。
  • 临床决策血运重建仍应基于卒中预防等主要适应证,而非认知改善。

局限性

  • 基线认知减退亚组样本量较小(51例),可能限制交互作用检验的效能。
  • 随访仅1年,无法评估更长期认知变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cerebral hemodynamic impairment in patients with asymptomatic internal carotid artery (ICA) stenosis is associated with reduced cognition. It is uncertain whether revascularization might be an effective treatment for cognitive impairment in these patients. OBJECTIVE: To test whether any cognitive benefit from revascularization of high-grade, asymptomatic ICA stenosis varies based on the degree of baseline cerebral hemodynamic impairment. DESIGN, SETTING, AND PARTICIPANTS: This substudy was conducted within a multicenter phase 3 randomized clinical trial. Adults (aged 35-86 years) without dementia with eighth-grade education or higher and unilateral asymptomatic ICA stenosis greater than or equal to 70% were enrolled from January 2018 to July 2024 at 61 sites in North America (last follow-up in July 2025). Of 607 participants screened from 2485 in CREST-2, 392 were enrolled. Magnetic resonance or computed tomographic perfusion imaging tested for baseline hemodynamic impairment defined by delayed time-to-peak (TTP) arrival of intravenous contrast in the hemisphere ipsilateral minus contralateral to the stenotic artery. INTERVENTION: Carotid revascularization (endarterectomy or stenting) plus intensive medical management (IMM) vs IMM alone. MAIN OUTCOMES AND MEASURES: The primary outcome was the difference in composite cognitive z score over 1 year based on 5 cognitive tests. The primary analysis tested for an interaction between treatment group (revascularization vs IMM alone) and degree of baseline hemodynamic impairment among those with reduced baseline cognition (cognitive z score ≤-1.0 SD). RESULTS: Of 392 participants enrolled (mean age, 71 years; 125 [32%] females), 61 were excluded for missing baseline imaging and 40 for missing cognitive examinations or other covariates, leaving 291 with complete data. Fifty-one had reduced cognition at baseline (25 in the revascularization group and 26 in the IMM alone group). TTP ranged from no interhemispheric TTP delay to a more-than-2-second delay. Mean (SD) cognitive z scores were -1.36 (0.51) at baseline and -1.17 (0.47) at 1 year in the revascularization group and -1.34 (0.83) at baseline and -1.01 (0.97) at 1 year in the IMM alone group. The primary analysis showed no difference in cognition by treatment group over 1 year, adjusting for treatment group × hemodynamic status interaction and other covariates (adjusted difference in cognitive z score, -0.15 SD [95% CI, -0.54 to 0.24]). The interaction was not significant (β estimate = 0.018 [95% CI, -0.025 to 0.061]; P = .40). CONCLUSIONS AND RELEVANCE: In this substudy of a randomized clinical trial, there was no differential effect of revascularization vs IMM alone on cognition over 1 year by cerebral hemodynamic status among those with baseline reduced cognition, suggesting that revascularization does not improve cognitive dysfunction by restoring flow to the brain in chronic asymptomatic carotid stenosis. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03121209.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Marshall RS, Lazar RM, Meschia JF, et al. Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial. JAMA. 2026. PMID: 42747834. doi:10.1001/jama.2026.13384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。